Literature DB >> 2538650

Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

C M Stoltzfus1, S J Fogarty.   

Abstract

Retrovirus replication requires the production of both spliced and unspliced viral RNA from a single RNA transcript. In contrast, cellular RNA precursors with introns almost completely spliced. The cis elements and virus-coded trans factors which determine the extent to which Rous sarcoma virus RNA is spliced to src mRNA were investigated by transfecting chicken embryo fibroblasts with cloned wild-type and mutant DNA followed by the analysis of viral RNA. Two cis-acting regions important in the negative control of splicing were detected. Cell cultures transfected with a clone deleted in 80% of the src intron (nucleotide 1149 to nucleotide 6574) demonstrated only a 2-fold reduction in the ratio of unspliced to spliced RNA relative to the wild-type clone, whereas cultures transfected with clones which were further deleted in the gag gene region (between nucleotide 630 and nucleotide 5258) demonstrated an approximate 20-fold reduction. Cell cultures which were transfected with clones deleted only between nucleotides 543 and 1806 demonstrated only a three- to fourfold reduction in the unspliced-to-spliced RNA ratio, suggesting that at least one other region of the src intron can partially compensate for the deletion of the gag region. Both regions appeared to act in cis on the distribution of unspliced and spliced RNA since the ratios were not altered by cotransfection with helper virus DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538650      PMCID: PMC248417     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Cloning and nucleotide sequences of cDNAs spanning the splice junctions of Rous sarcoma virus mRNAs.

Authors:  L J Chang; C M Stoltzfus
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

2.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

3.  A minimal intron length but no specific internal sequence is required for splicing the large rabbit beta-globin intron.

Authors:  B Wieringa; E Hofer; C Weissmann
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

4.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

5.  Alternative splicing caused by RNA secondary structure.

Authors:  D Solnick
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

6.  Insertion of several different DNAs in reticuloendotheliosis virus strain T suppresses transformation by reducing the amount of subgenomic mRNA.

Authors:  C K Miller; H M Temin
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

7.  Avian sarcoma virus gag and env gene structural protein precursors contain a common amino-terminal sequence.

Authors:  T A Ficht; L J Chang; C M Stoltzfus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment.

Authors:  M A Lopata; D W Cleveland; B Sollner-Webb
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

9.  Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA.

Authors:  L S Hwang; J Park; E Gilboa
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

10.  Transduction of a cellular oncogene: the genesis of Rous sarcoma virus.

Authors:  R Swanstrom; R C Parker; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  44 in total

1.  The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.

Authors:  C S Hibbert; R R Gontarek; K L Beemon
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

2.  Retroviral splicing suppressor requires three nonconsensus uridines in a 5' splice site-like sequence.

Authors:  R E Paca; C S Hibbert; C T O'Sullivan; K L Beemon
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus.

Authors:  H A Brady; A Scaria; W S Wold
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.

Authors:  S Schwartz; M Campbell; G Nasioulas; J Harrison; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA.

Authors:  J T Miller; C M Stoltzfus
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.

Authors:  Nicole L Maciolek; Mark T McNally
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

7.  Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing.

Authors:  S L Berberich; C M Stoltzfus
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.

Authors:  Z H Si; D Rauch; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.

Authors:  B A Amendt; D Hesslein; L J Chang; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant.

Authors:  L Zhang; S B Simpson; C M Stoltzfus
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.